首页> 外文期刊>Pharmacology: International Journal of Experimental and Clinical Pharmacology >Comparison of the Efficacy of Olopatadine and Fexofenadine in Chronic Idiopathic Urticaria Patients: A Crossover Study
【24h】

Comparison of the Efficacy of Olopatadine and Fexofenadine in Chronic Idiopathic Urticaria Patients: A Crossover Study

机译:厄洛他定和非索非那定在慢性特发性荨麻疹患者中的疗效比较:一项交叉研究

获取原文
获取原文并翻译 | 示例
           

摘要

Olopatadine is one of the second-generation H-1 antihistamines that were used for treating allergic disorders initially in Asia, and now also in Western countries. Whereas several trials compared the efficacy on chronic urticaria among second-generation H-1 antihistamines, no study has directly compared the clinical efficacy between olopatadine and other H-1 antihistamines in patients with chronic idiopathic urticaria (CIU). In this study, we address this issue for the first time and conclude that olopatadine is a good candidate for the treatment of CIU. (C) 2015 S. Karger AG, Basel
机译:奥洛他定是第二代H-1抗组胺药之一,最初在亚洲用于治疗过敏性疾病,现在在西方国家也用于治疗。尽管有几项试验比较了第二代H-1抗组胺药对慢性荨麻疹的疗效,但尚无直接比较奥洛他定和其他H-1抗组胺药对慢性特发性荨麻疹(CIU)患者的临床疗效的研究。在这项研究中,我们首次解决了这个问题,并得出结论,奥洛他定是治疗CIU的好人选。 (C)2015 S.Karger AG,巴塞尔

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号